Daiichi Sankyo Co Ltd. Buys 20 Percent Stake in Ranbaxy Laboratories

TOKYO, Oct 17 (Reuters) - Japan's Daiichi Sankyo Co said on Friday it had completed the purchase of 20 percent in India's Ranbaxy Laboratories, part of its plan to obtain a majority holding in the generic drugmaker.